News|Articles|October 2, 2025

Q3 recap: What's new in obstetrics and gynecology?

Fact checked by: Celeste Krewson, Assistant Editor

Take a quick look at everything you may have missed during the third quarter of 2025, including the latest FDA approvals, top stories, and exclusive interviews.

As we near the finish of 2025, the third quarter (Q3) has delivered major advancements across cervical cancer screening, infectious disease management, and preventive women’s health.